Affordable Access Orifarm is a leading European supplier of parallel imported and generic pharmaceuticals with a mission to lower healthcare costs. This creates sales opportunities with public health systems and pharmacies seeking cost-effective procurement and broad-access programs.

European Growth Recent leadership additions and strategic funding plans indicate an aggressive European expansion. Seek partnerships or distribution deals with national wholesalers, hospital networks, and pharmacy chains across Denmark, Germany, and neighboring markets to support growth targets.

Diversification Moves Orifarm recently divested 16 vitamins and supplements brands to STADA and continues to diversify through new business areas. This signals openness to strategic partnerships in both core generics and adjacent consumer healthcare categories.

Strategic Investments The Fit to Scale plan aims to significantly grow revenue and EBITDA by 2031. Align sales conversations around value-based procurement, cost savings for healthcare systems, and scalable supply agreements that support rapid geographic expansion.

Leadership & Talent New CFO and CIO appointments, plus a chief people officer in 2023, highlight a disciplined, data-driven approach to growth. Propose enterprise-level deals with robust governance, digital integration, and transparency in forecasting and performance reporting.